000			01949 a2200565 4500
005			20250516185107.0
264		0	_c20140930
008			201409s 0 0 eng d
022			_a1932-6203
024	7		_a10.1371/journal.pone.0083013 _2doi
040			_aNLM _beng _cNLM
100	1		_aWu, Xue-Feng
245	0	0	_aBeauvericin ameliorates experimental colitis by inhibiting activated T cells via downregulation of the PI3K/Akt signaling pathway. _h[electronic resource]
260			_bPloS one _c2013
300			_ae83013 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aApoptosis
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aColitis _xchemically induced
650	0	4	_aDepsipeptides _xtherapeutic use
650	0	4	_aDisease Models, Animal
650	0	4	_aDown-Regulation
650	0	4	_aFemale
650	0	4	_aFlow Cytometry
650	0	4	_aGene Expression Regulation, Enzymologic
650	0	4	_aInflammation
650	0	4	_aInterferon-gamma _xmetabolism
650	0	4	_aLymphocyte Activation _xdrug effects
650	0	4	_aMembrane Potential, Mitochondrial _xdrug effects
650	0	4	_aMice
650	0	4	_aMice, Inbred BALB C
650	0	4	_aPhosphatidylinositol 3-Kinases _xmetabolism
650	0	4	_aPhosphorylation
650	0	4	_aProto-Oncogene Proteins c-akt _xmetabolism
650	0	4	_aSignal Transduction
650	0	4	_aT-Lymphocytes _xdrug effects
650	0	4	_aTrinitrobenzenesulfonic Acid _xchemistry
650	0	4	_aTumor Necrosis Factor-alpha _xmetabolism
700	1		_aXu, Rui
700	1		_aOuyang, Zi-Jun
700	1		_aQian, Cheng
700	1		_aShen, Yan
700	1		_aWu, Xu-Dong
700	1		_aGu, Yan-Hong
700	1		_aXu, Qiang
700	1		_aSun, Yang
773	0		_tPloS one _gvol. 8 _gno. 12 _gp. e83013
856	4	0	_uhttps://doi.org/10.1371/journal.pone.0083013 _zAvailable from publisher's website
999			_c23369053 _d23369053